Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyoma × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 29 Breast Neoplasms 23 Lung Neoplasms 22 Carcinoma, Non-Small-Cell Lung 22 Colonic Neoplasms 15 Head and Neck Neoplasms 13 Rectal Neoplasms 12 Prostatic Neoplasms 11 Sarcoma 8 Neoplasm Metastasis 8 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Neoplasms 6 Mouth Neoplasms 6 Glioblastoma 6 Precancerous Conditions 5 Ovarian Neoplasms 5 Melanoma 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Neuroblastoma 4 Gliosarcoma 4 Carcinoma 4 Urinary Bladder Neoplasms 3 Oropharyngeal Neoplasms 3 Multiple Myeloma 3

Interventions

ulipristal acetate 18 Uterine Myomectomy 17 telapristone acetate 16 vilaprisan 11 Uterine Artery Embolization 10 relugolix 9 Leuprolide 9 asoprisnil 7 Mifepristone 7 ulipristal 6 estradiol, norethindrone drug combination 6 elagolix 6 Tranexamic Acid 6 Hysterectomy 6 Estradiol 6 Bupivacaine 6 Norethindrone Acetate 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Saline Solution 4 Letrozole 4 Vitamin B 6 3 Radiofrequency Ablation 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01555073 2016-07-28

Preemptive Analgesia Following Uterine Artery Embolization

Northwestern University

Phase 4 Terminated

23 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡